Clinical Trials Logo

Filter by:
NCT ID: NCT00638183 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Special Survey Long-term Treatment With Tiotropium on COPD

Start date: April 2005
Phase: N/A
Study type: Observational

Since Spiriva Inhalation Capsules 18mcg (hereinafter this product) are indicated for treatment of patients with chronic obstructive pulmonary disease (i.e. patients with chronic bronchitis or pulmonary emphysema) and usually intended for long-term use, the present survey is conducted to collect safety and effectiveness information on the use of this product for long period of time in daily clinical settings, and to obtain proper drug use information.

NCT ID: NCT00637377 Completed - Clinical trials for Macular Degeneration

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

VIEW 2
Start date: April 2008
Phase: Phase 3
Study type: Interventional

This study is a phase III, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration. Approximately 1200 patients will be randomized in Europe, Asia, Japan, Australia and South America.

NCT ID: NCT00636831 Completed - Inguinal Hernia Clinical Trials

Prophylactic Antibiotic Use in Hernioplasty

RCT-herniation
Start date: July 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether prophylactic antibiotic use in inguinal hernioplasty are effective in prevention of infectious complication.

NCT ID: NCT00635401 Completed - Smoking Clinical Trials

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

Start date: May 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of varenicline in Japanese smokers. Efficacy is evaluated by continuous quit rate and withdrawal symptoms of smokers. Safety is evaluated by adverse events, laboratory tests, and other safety tests.

NCT ID: NCT00635336 Completed - Bladder Cancer Clinical Trials

Novel Peptide Vaccination for Patients With Advanced Bladder Cancer

Start date: February 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and clinical efficacy of novel vaccination for advanced bladder cancer.

NCT ID: NCT00634946 Completed - Clinical trials for Lumbar Vertebra Hernia

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

Start date: January 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether SI-6603 is effective in the treatment of lumbar disc herniation.

NCT ID: NCT00634114 Completed - Reflux Esophagitis Clinical Trials

Reflux Esophagitis Phase III Study (Maintenance Treatment)

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of esomeprazole 20 mg once daily for 24 weeks on maintenance of Reflux Esophagitis in patients with healed reflux esophagitis in comparison with omeprazole 10 mg once daily and esomeprazole 10 mg once daily by assessment of presence/absence of recurrence of Reflux Esophagitis throughout the treatment period (from the randomisation to the treatment completion) according to the Los Angeles classification.

NCT ID: NCT00633932 Completed - Reflux Esophagitis Clinical Trials

Reflux Esophagitis Phase III Study (Initial Treatment)

Start date: December 2007
Phase: Phase 3
Study type: Interventional

This study is to evaluate the efficacy of esomeprazole 20 mg once daily and 40 mg once daily for 8 weeks on healing of Reflux Esophagitis in patients with reflux esophagitis in comparison with omeprazole 20 mg once daily by assessment of presence/absence of Reflux Esophagitis at Week 8 according to the Los Angeles classification .

NCT ID: NCT00633724 Completed - Clinical trials for Non Small Cell Lung Cancer

Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer

Start date: May 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, immune response and clinical response of different doses of HLA-A*2402 restricted epitope peptides URLC10, TTK, VEGFR1 and VEGFR2 emulsified with Montanide ISA 51.

NCT ID: NCT00632554 Completed - Chronic Disease Clinical Trials

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Start date: June 2008
Phase: Phase 4
Study type: Interventional

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.